Connect Biopharma Holdings Limited Stock price
Equities
CNTB
US2075231017
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.724 USD | +7.08% | +37.90% | +44.92% |
Mar. 27 | ADRs End Higher; Connect Biopharma Holdings Climbs 21% | DJ |
Mar. 04 | HC Wainwright Starts Coverage on Connect Biopharma With Buy Rating, $7 Price Target | MT |
Sales 2023 * | 150M 20.79M | Sales 2024 * | 610M 84.36M | Capitalization | 641M 88.69M |
---|---|---|---|---|---|
Net income 2023 * | -326M -45.12M | Net income 2024 * | -215M -29.75M | EV / Sales 2023 * | -2.62 x |
Net cash position 2023 * | 1.03B 143M | Net cash position 2024 * | 830M 115M | EV / Sales 2024 * | -0.31 x |
P/E ratio 2023 * |
-1.95
x | P/E ratio 2024 * |
-2.97
x | Employees | 100 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 56.35% |
Latest transcript on Connect Biopharma Holdings Limited
1 day | +21.05% | ||
1 week | +28.80% | ||
Current month | +36.44% | ||
1 month | +27.78% | ||
3 months | +61.00% | ||
6 months | +120.55% | ||
Current year | +36.44% |
Managers | Title | Age | Since |
---|---|---|---|
Zheng Wei
FOU | Founder | 61 | 15-11-22 |
Wubin Pan
FOU | Founder | 60 | 12-04-30 |
Steven Chan
DFI | Director of Finance/CFO | 52 | 21-11-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jean Liu
BRD | Director/Board Member | 55 | 21-08-22 |
Director/Board Member | 66 | 20-11-30 | |
Karen Wilson
BRD | Director/Board Member | 61 | 20-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 115 M€ | +4.54% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1.724 | +7.08% | 445 137 |
24-03-27 | 1.61 | +21.05% | 367,829 |
24-03-26 | 1.33 | +4.72% | 134,388 |
24-03-25 | 1.27 | -0.78% | 111,161 |
24-03-22 | 1.28 | +3.23% | 68,139 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.44% | 88.67M | |
+2.56% | 108B | |
+10.02% | 104B | |
+6.64% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |